Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review
Thank you for Subscribing to Healthcare Business Review Weekly Brief
ClearDATA and Send Mammogram Collaborate to Protect Women's Healthcare Data Together
“We’re proud to partner with an organization like Send Mammogram, doing so much good for breast care,” says Rick Froehlich, ClearDATA CEO.
By
Healthcare Business Review | Monday, October 31, 2022
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
The cybersecurity solutions from ClearDATA enable femtech innovator Send Mammogram to revolutionize breast imaging dissemination without compromising women's privacy.
FREMONT, CA: “We’re proud to partner with an organization like Send Mammogram, doing so much good for breast care,” says Rick Froehlich, ClearDATA CEO. “We can think of no better mission and are thrilled that ClearDATAs managed health cloud services have provided Send Mammogram with the highest confidence that sensitive patient data will remain private as they continue the important work of modernizing women's healthcare.” Healthcare's largest managed cloud and defense provider, ClearDATA®, has collaborated with Send Mammogram, a cloud-based technology that enables patients to share mammogram images and results with clinicians and diagnosticians, to help protect private health data during Breast Cancer Awareness Month.
Send Mammogram is a safe smartphone and web tool that is digitally revolutionizing the way patients and doctors ask for and exchange current and historical breast health photos, which in turn helps to enhance diagnosis and the quality of breast care for millions of women.
Tillata Gibson began her medical career as a mammography technician. In this role, she witnessed a severe issue that had not yet been addressed: the lack of access to previous breast imaging, which can result in unnecessary radiation exposure and tests and increase the risk of catastrophic complications throughout the entire spectrum of cancer prevention and treatmen